0001493152-24-008213.txt : 20240228 0001493152-24-008213.hdr.sgml : 20240228 20240228170006 ACCESSION NUMBER: 0001493152-24-008213 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cingulate Inc. CENTRAL INDEX KEY: 0001862150 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863825535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-93147 FILM NUMBER: 24696530 BUSINESS ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 BUSINESS PHONE: (913) 942-2300 MAIL ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Werth Peter J. CENTRAL INDEX KEY: 0001883257 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: C/O CINGULATE INC. STREET 2: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 SC 13D/A 1 formsc13da.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 9)*

 

Cingulate Inc.
(Name of Issuer)
 
COMMON STOCK, PAR VALUE $0.0001 PER SHARE
(Title of Class of Securities)
 
17248W204
(CUSIP Number)
 

Shane J. Schaffer

Chief Executive Officer

1901 W. 47th Place

Kansas City, KS 66205

Telephone Number (913) 942-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 
February 26, 2024
(Date of Event Which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

 

 

 

 

 

CUSIP No.   17248W204  
1. Names of Reporting Persons.  I.R.S. Identification Nos. of above persons (entities only):  
  Peter J. Werth  
2. Check the Appropriate Box if a Member of a Group (a) ☐
    (b) ☐
3. SEC Use Only  
4. Source of Funds (See Instructions):   PF  
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e):  
              ☐  
6. Citizenship or Place of Organization:    United States  

  Number of 7. Sole Voting Power: 1,768*
  Shares Beneficially 8. Shared Voting Power: 1,169,287*
  Owned by    
  Each Reporting 9. Sole Dispositive Power: 1,768*
  Person With 10. Shared Dispositive Power: 1,169,287*

11. Aggregate Amount Beneficially Owned by Each Reporting Person:
  1,171,055*
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):
              ☐
13. Percent of Class Represented by Amount in Row (11):    19.95%*
14. Type of Reporting Person (See Instructions):   IN

 

*As of the date hereof, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Peter J. Werth (“Mr. Werth”) may be deemed to beneficially own an aggregate of 1,171,055 shares of common stock, par value $0.0001 per share (the “Common Stock”), of Cingulate Inc. (the “Issuer”) consisting of (i) 1,093 shares of Common Stock and stock options to purchase 675 shares of Common Stock held directly by Mr. Werth and (ii) 139,917 shares of Common Stock and warrants to purchase up to 1,029,370 shares of Common Stock held directly by Werth Family Investment Associates LLC (“Werth Associates”) where Mr. Werth serves as Manager. Excludes 975 shares of Common Stock underlying unvested stock options held directly by Mr. Werth.

 

The foregoing reported beneficial ownership percentage is based upon 4,839,471 shares of Common Stock issued and outstanding as of February 27, 2024. The number of shares of Common Stock issued and outstanding reflects the 1-for-20 reverse stock split of the Issuer’s issued and outstanding shares of Common Stock, which became effective on November 30, 2023.

 

 

 

 

CUSIP No.  17248W204  
1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only):  
  Werth Family Investment Associates LLC  
2. Check the Appropriate Box if a Member of a Group (a) ☐
    (b) ☐
3. SEC Use Only  
4. Source of Funds (See Instructions):    WC  
5. Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e):  
              ☐  
6. Citizenship or Place of Organization:    Connecticut  

  Number of 7. Sole Voting Power: 0
  Shares Beneficially 8. Shared Voting Power: 1,169,287**
  Owned by    
  Each Reporting 9. Sole Dispositive Power: 0
  Person With 10. Shared Dispositive Power: 1,169,287**

11. Aggregate Amount Beneficially Owned by Each Reporting Person:
  1,169,287**
12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):
              ☐
13. Percent of Class Represented by Amount in Row (11):    19.92%**
14. Type of Reporting Person (See Instructions):   OO

 

** As of the date hereof, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Werth Family Investment Associates LLC (“Werth Associates”) may be deemed to beneficially own 1,169,287 shares of common stock, par value $0.0001 per share (the “Common Stock”), of Cingulate Inc. (the “Issuer”), consisting of 139,917 shares of Common Stock and warrants to purchase up to 1,029,370  shares of Common Stock.

 

The foregoing reported beneficial ownership percentage is based upon 4,839,471 shares of Common Stock issued and outstanding as of February 27, 2024. The number of shares of Common Stock issued and outstanding reflects the 1-for-20 reverse stock split of the Issuer’s issued and outstanding shares of Common Stock, which became effective on November 30, 2023.

 

 

 

 

Explanatory Note

 

This Amendment No. 9 (this “Amendment”) amends and supplements the Schedule 13D filed on behalf of the Reporting Persons with the Securities and Exchange Commission on December 20, 2021, as amended on December 23, 2022, July 25, 2023, August 14, 2023, September 18, 2023, November 8, 2023, January 4, 2024, January 29, 2024 and February 9, 2024 (the “Schedule 13D”). Except as specifically provided herein, this Amendment does not modify or amend any of the information previously reported in the Schedule 13D. Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

 

The number of shares of Common Stock issued and outstanding reflects the 1-for-20 reverse stock split of the Issuer’s issued and outstanding shares of Common Stock, which became effective on November 30, 2023.

 

 

 

 

Item 5. Interest in Securities of the Issuer.

 

The information contained in rows 7, 8, 9, 10, 11 and 13 of the cover page of this Schedule 13D and the information set forth in or incorporated by reference in Item 2, Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5.

 

The aggregate percentage of Common Stock reported owned by the Reporting Persons is based upon 4,839,471 shares of Common Stock outstanding, which is the total number of shares of Common Stock outstanding as of February 27, 2024. The number of shares of Common Stock issued and outstanding reflects the 1-for-20 reverse stock split of the Issuer’s issued and outstanding shares of Common Stock, which became effective on November 30, 2023.

 

As of the date hereof, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Werth may be deemed to beneficially own 1,171,055 shares of Common Stock of the Issuer, consisting of (i) 1,093 shares of Common Stock and stock options to purchase 675 shares of Common Stock held directly by Mr. Werth and (ii) 139,917 shares of Common Stock and warrants to purchase up to 1,029,370 shares of Common Stock held directly by Werth Associates.

 

Except as described herein, during the past sixty (60) days on or prior to the date hereof, there were no other purchases or sales of shares of Common Stock, or securities convertible into or exchangeable for shares of Common Stock, by the Reporting Persons or any person or entity for which the Reporting Persons possess voting or dispositive control over the securities thereof.

 

 

 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  February 28, 2024

 

  By: /s/ Peter J. Werth*
    Peter J. Werth

 

  WERTH FAMILY INVESTMENT ASSOCIATES LLC
                
  By: Peter J. Werth, its Manager

 

  By: /s/ Peter J. Werth
  Name: Peter J. Werth
  Title: Manager

 

* This reporting person disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that any such person is the beneficial owner of these securities for purposes of Section 16 of the U.S. Securities Exchange Act of 1934, as amended, or for any other purpose.

 

Attention: Intentional misstatements or omissions of fact constitute

Federal criminal violations (see 18 U.S.C. 1001).